Importantly, one has to keep in mind that autoimmunity and exogenous antigens are not mutually exclusive. For example, monoclonal rheumatoid factors react with the Fc portion of IgG to form mixed ...
Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.